Home » Topics » BioWorld Science

BioWorld Science
RSS

Merck & Co. discovers IDO1 inhibitors

May 30, 2019

Phase III KALM-1 study of Korsuva in hemodialysis patients with pruritus meets primary endpoint

May 30, 2019

Jubilant Biosys describes PD-1/PD-L1 interaction inhibitors

May 30, 2019

Metacrine reports phase Ib interim data on FXR agonist MET-409 in NASH

May 30, 2019

German researchers present new adenosine A2A receptor ligands

May 30, 2019

Xeomin approved in E.U. for treatment of chronic sialorrhea in adults

May 30, 2019

Sumitomo Dainippon Pharma patents TLR7 antagonists

May 30, 2019

Medshine Discovery divulges mTORC1 and mTORC2 inhibitors

May 30, 2019

Gut-derived live bacterial strains found to modulate neuroinflammation and neurodegeneration in PD

May 30, 2019

TRPV1 as a novel target in gastric cancer therapy

May 30, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...